创金合信全球医药生物股票发起(QDII)C(018156)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2025-09-29 |
6,502,339.89 |
18,120,721.96 |
17,795,032.43 |
6,176,650.36 |
| 2025-06-29 |
6,637,748.54 |
6,502,339.89 |
3,359,240.77 |
3,494,649.42 |
| 2025-03-30 |
7,098,894.44 |
6,637,748.54 |
4,405,595.91 |
4,866,741.81 |
| 2024-12-30 |
5,898,557.71 |
7,098,894.44 |
2,717,008.35 |
1,516,671.62 |
| 2024-09-29 |
6,309,012.66 |
5,898,557.71 |
1,308,403.60 |
1,718,858.55 |
| 2024-06-29 |
6,200,421.19 |
6,309,012.66 |
491,319.57 |
382,728.10 |
| 2024-03-30 |
6,991,986.00 |
6,200,421.19 |
474,957.75 |
1,266,522.56 |
微信公众号
证券之星APP
基本资料
